Safety and Efficacy of YPEG-rhG-CSF in Cancer Patients Receiving Chemotherapy
Clinical trial NCT02005458 · COMPLETED
Trial details
- NCT number
- NCT02005458
- Sponsor
- Xiamen Amoytop Biotech Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-01
- Primary completion
- 2017-03-01
- Enrollment
- 80
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.